New drug addresses long overlooked "negative" symptoms of schizophrenia
Read now →A data-driven search found a compound that shows promising results in early trials
3 peer comments
Elizabeth Burnette
Neuroscience
University of California, Los Angeles
Elizabeth is a neuroscientist and science communicator with a broad interest in clinical neuroscience. She is currently pursuing a Ph.D. in neuroscience at UCLA, studying addiction, specifically Alcohol Use Disorder, in human clinical populations. Her research uses functional neuroimaging (fMRI) and psychoneuroimmunology (PNI) methods. She received her B.S. in neuroscience from Duke in 2018. Outside the lab, she is also a content producer, contributing editor, and podcast host for Knowing Neurons.
Why does COVID-19 often cause brain fog?
Read now →Low oxygen supplies in the brain make it difficult to think and carry out every day activities
Your brain responds to why you're drinking, not just what you're drinking
Read now →Drinking for relief produces a different reaction in the brain than drinking for reward does
Can the criminal justice system's artificial intelligence ever be truly fair?
Read now →Computer programs used in 46 states incorrectly label Black defendants as “high-risk” at twice the rate as white defendants
3 peer comments
How seven cases of a mysterious opioid-induced disease revolutionized Parkinson's research
Read now →In the early 1980s, seven people took synthetic heroin. What happened next drastically changed our understanding of Parkinson's disease, and how to treat it
2 peer comments